Indivior (INDV)

 

INDV Share PerformanceMore

52 week high421.50 23/08/17
52 week low246.50 01/09/17
52 week change -22.20 (-6.68%)
4 week volume73,204,783 24/08/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Broker Forecast - Stifel issues a broker note on Indivior Plc

Stifel today reaffirms its buy investment rating on Indivior Plc (LON:INDV) and set its price target at 400p.

North Korea's latest missile test scares investors

Investors were concerned following North Korea's latest missile test over Japan, causing investors to be nervous about geop...

JD Wetherspoon gains momentum on strong results

Investors raised a glass to budget-friendly pub chain JD Wetherspoon (JDW) after pre-tax profit before exceptional items r...

Indivior asserts new patent against ANDA-filers

Indivior's US subsidiary, Indivior Inc, has filed patent lawsuits against Dr Reddy's, Actavis, Par, Alvogen, Teva, and Mylan ...

Indivior asserts new patent against ANDA-filers

RNS Number: 8297Q Indivior PLC 15 September 2017 Indivior files complaints asserting new SUBOXONE Film patent against ANDA-filers Slough, UK, 15 September 2017 - Indivior PLC (LON: INDV) ("Indivior" or the "Company") today announced that its U.S. subsidiary, Indivior Inc., has filed patent lawsuits against Dr. Reddy's, Actavis, Par, Alvogen, Teva, and My...

Holding(s) in Company

RNS Number: 3588Q Indivior PLC 11 September 2017 TR-1: S tandard form for notification of major holdings 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: Indivior PLC 1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate) Non-UK issuer 2. Reason for the notification (ple...

Broker Forecast - Jefferies International issues a broker note on Indivior Plc

Jefferies International today reaffirms its buy investment rating on Indivior Plc (LON:INDV) and cut its price target to 35...

A small-cap pharma still smashing City forecasts

This hugely lucrative AIM drug company has wowed its cheerleaders in the City again. David Brenchley asks whether its i...

Latest discussion posts More

  • Topped up

    Decided the fall was overdone, as income will be unaffected while the appeal drags on (>18 months minimum), and in the meantime the pipeline will gain approval and diversify ...
    7-Sep-2017
    picstloup
  • Re: NEW ARTICLE: Why this 40% slump is a...

    A rough price ( CG base for tax base ) based on RB price at spin off, #120. #1.20 + 17% = 140p
    2-Sep-2017
    Ripley94
  • Re: NEW ARTICLE: Why this 40% slump is a buy...

    Spun out of Reckitt bebckiser ( RB ) Christmas 2014. Dropped 36% After us court set back regarding its opioid drug the flagship suboxone. City loved it when it floated first ...
    2-Sep-2017
    Ripley94

Users' HoldingsMore

Users who hold Indivior also hold..
RECKITT BEN. GP63%
GLAXOSMITHKLINE42%
NATIONAL GRID32%
VODAFONE GRP.31%
RDS 'B'29%

Codes & Symbols

ISINGB00BRS65X63
SymbolsINDV, LSE:INDV, INDV.L, INDV:LN, LON:INDV, XLON:INDV